R. Douglas Norby, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 2,000 shares at $61.59 ($123K) on 2008-02-20, disclosed to the SEC on 2008-02-20.
Open-market sale of $123k ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.57 | 1,400 | $86K | 70.0% |
| 2 | $61.59 | 600 | $37K | 30.0% |
| Total | $61.58 avg | 2,000 | $123K | 100% |
| Filing → |
| ALXN | SELL | 2013-05-23 | $4.1M | — | Filing → |
| ALXN | SELL | 2012-12-12 | $2.0M | — | Filing → |
| ALXN | SELL | 2012-03-12 | $2.6M | — | Filing → |